Acceptance and long-term compliance with nCPAP in patients with obstructive sleep apnoea syndrome

Previous studies have generally shown poor effective long-term compliance with nasal continuous positive airway pressure (nCPAP) in patients with obstructive sleep apnoea syndrome (OSAS). We performed a retrospective study of patients treated with nCPAP for more than one year. Compliance was defined as the average number of hours of nCPAP use per day, where hours of use were obtained from the built-in time counter of the nCPAP device, after deduction of the 10% difference between effective use and time counters previously shown by others. We present data on the first 95 patients for whom results were available. The follow-up period was 784 +/- 366 (mean +/- SD) days for the whole group. Compliance was 5 +/- 1.8 h. For a subgroup of 36 patients, we had data on two consecutive follow-up periods (673 +/- 235 and 390 +/- 147 days for the first and second period, respectively). Compliance remained stable (5.2 +/- 1.5 and 5 +/- 2.3 h, respectively). For the whole group, a significant correlation was found between compliance and sleep fragmentation expressed as the movement arousal index (r = 0.226). During a similar 3 year period, 155 patients with a confirmed diagnosis of OSAS were offered a nCPAP trial. CPAP was actually delivered for home use to 117 patients (76%). During this same 3 year period, only 21 patients out of a total of 192 followed-up in our institution quit treatment, mainly due to intolerance or cure. These results indicate that in a nonselected group of obstructive sleep apnoea syndrome patients a high and stable compliance with nasal continuous positive pressure can be achieved, contradicting recent results of other series.

This article has been cited by other articles:

				S. Olsen, S. Smith, T. Oei, and J. Douglas Health belief model predicts adherence to CPAP before experience with CPAP Eur. Respir. J., September 1, 2008; 32(3): 710 - 717. [Abstract] [Full Text] [PDF]

				H.-S. Lin, A. S. Prasad, C.-J. G. Pan, and J. A. Rowley Factors Associated With Noncompliance to Treatment With Positive Airway Pressure Arch Otolaryngol Head Neck Surg, January 1, 2007; 133(1): 69 - 72. [Abstract] [Full Text] [PDF]

				M. Sucena, G. Liistro, G. Aubert, D. O. Rodenstein, and T. Pieters Continuous positive airway pressure treatment for sleep apnoea: compliance increases with time in continuing users. Eur. Respir. J., April 1, 2006; 27(4): 761 - 766. [Abstract] [Full Text] [PDF]

				P. Lloberes, S. Marti, G. Sampol, A. Roca, T. Sagales, X. Munoz, and M. Ferrer Predictive Factors of Quality-of-Life Improvement and Continuous Positive Airway Pressure Use in Patients With Sleep Apnea-Hypopnea Syndrome: Study at 1 Year Chest, October 1, 2004; 126(4): 1241 - 1247. [Abstract] [Full Text] [PDF]

				M K Johnson, R Carter, A Nicol, R Paton, and S W Banham Long-term continuous positive airway pressure (CPAP) outcomes from a sleep service using limited sleep studies and daycase CPAP titration in the management of obstructive sleep apnoea/hypopnoea syndrome Chronic Respiratory Disease, April 1, 2004; 1(2): 83 - 88. [Abstract] [PDF]

				N. MCARDLE and N. J. DOUGLAS Effect of Continuous Positive Airway Pressure on Sleep Architecture in the Sleep Apnea-Hypopnea Syndrome . A Randomized Controlled Trial Am. J. Respir. Crit. Care Med., October 15, 2001; 164(8): 1459 - 1463. [Abstract] [Full Text] [PDF]

				O. Parra Sleep-disordered breathing and stroke: is there a rationale for treatment? Eur. Respir. J., October 1, 2001; 18(4): 619 - 622. [Full Text] [PDF]

				T.E. Wessendorf, Y-;M. Wang, A.F. Thilmann, U. Sorgenfrei, N. Konietzko, and H. Teschler Treatment of obstructive sleep apnoea with nasal continuous positive airway pressure in stroke Eur. Respir. J., October 1, 2001; 18(4): 623 - 629. [Abstract] [Full Text] [PDF]

				G Popescu, M Latham, V Allgar, and M W Elliott Continuous positive airway pressure for sleep apnoea/hypopnoea syndrome: usefulness of a 2 week trial to identify factors associated with long term use Thorax, September 1, 2001; 56(9): 727 - 733. [Abstract] [Full Text] [PDF]

				D. S. C Hui, D. K. L. Choy, T. S. T. Li, F. W. S. Ko, K. K. Wong, J. K. W. Chan, and C. K. W. Lai Determinants of Continuous Positive Airway Pressure Compliance in a Group of Chinese Patients With Obstructive Sleep Apnea Chest, July 1, 2001; 120(1): 170 - 176. [Abstract] [Full Text] [PDF]

				J. Harbison, P. O'Reilly, and W. T. McNicholas Cardiac Rhythm Disturbances in the Obstructive Sleep Apnea Syndrome : Effects of Nasal Continuous Positive Airway Pressure Therapy Chest, September 1, 2000; 118(3): 591 - 595. [Abstract] [Full Text] [PDF]

				J. L. PÉPIN, J. KRIEGER, D. RODENSTEIN, A. CORNETTE, E. SFORZA, P. DELGUSTE, C. DESCHAUX, V. GRILLIER, and P. LÉVY Effective Compliance during the First 3 Months of Continuous Positive Airway Pressure . A European Prospective Study of 121 Patients Am. J. Respir. Crit. Care Med., October 1, 1999; 160(4): 1124 - 1129. [Abstract] [Full Text]

				C. J. HOY, M. VENNELLE, R. N. KINGSHOTT, H. M. ENGLEMAN, and N. J. DOUGLAS Can Intensive Support Improve Continuous Positive Airway Pressure Use in Patients with the Sleep Apnea/Hypopnea Syndrome? Am. J. Respir. Crit. Care Med., April 1, 1999; 159(4): 1096 - 1100. [Abstract] [Full Text] [PDF]

				N. MCARDLE, G. DEVEREUX, H. HEIDARNEJAD, H. M. ENGLEMAN, T. W. MACKAY, and N. J. DOUGLAS Long-term Use of CPAP Therapy for Sleep Apnea/Hypopnea Syndrome Am. J. Respir. Crit. Care Med., April 1, 1999; 159(4): 1108 - 1114. [Abstract] [Full Text] [PDF]